ClinicalTrials.gg
Not yet recruitingNCT07665385Updated Jun 30, 2026

Trial of Management of Chronic Tinnitus by Sound Therapy and Cognitive Behavioral Therapy

An interventional study of Group A: sound therapy and Group B: Cognitive Behavioral Therapy in Chronic Subjective Tinnitus, sponsored by Sohag University. Not yet recruiting at 1 site in Egypt. Open to participants aged 18 Months to 65 Months. Per ClinicalTrials.gov, last updated 2026-06-30.

Sponsored by Sohag University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Months to 65 Months
Sex
All
01

Study summary

clinical trial: The main aim of this study is to compare the effectiveness of Cognitive Behavioral Therapy (CBT) and Sound Therapy, both individually and in combination, in the management of patients with chronic subjective tinnitus and to evaluate their impact on decreasing tinnitus severity, psychological wellbeing and quality of life.

Patients will be randomly divided into three groups:

  • Group A: patients will receive Sound Therapy.
  • Group B: patients will receive Cognitive Behavioral Therapy (CBT).
  • Group C: patients will receive Combined CBT + Sound Therapy.
Read the detailed description

Because of the multifactorial nature of tinnitus, its effective management requires a multidisciplinary approach. While there is no single pullet mechanism of cure, current treatment strategies primary focus on reducing tinnitus related perception and minimizing its associated distress through auditory and psychological interventions.

Among these approaches, is the Sound Therapy which aims to decrease the contrast between tinnitus and related neural activity by introducing external sounds, which facilitates habituation and reducing tinnitus perception .

In contrast, Cognitive Behavioral Therapy (CBT) targets the patient's cognitive and emotional reaction to tinnitus by modifying maladaptive thoughts and behaviors, there by improving coping strategies and reducing tinnitus-related distress (Andersson, 2011). Recent evidence suggests that combining both modalities may provide superior outcomes compared to either approach alone, highlighting the potential value for integrated treatment strategies in tinnitus management (Hall et

02

Conditions studied

  • Chronic Subjective Tinnitus

Browse trials for

Keywords

  • Sound Therapy
  • Cognitive Behavioral Therapy
  • Chronic Tinnitus
  • Subjective Tinnitus
  • Tinnitus
03

In context

Tinnitus

444 studies on the registry are indexed under Tinnitus; 98 are open to participants now.

This study's planned enrollment of 60 is close to the median of 60 across 368 interventional studies indexed under Tinnitus.

Browse Tinnitus studies →

Lead sponsor

Sohag University is the lead sponsor of 1,230 studies on the registry; 636 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Months to 65 Months
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • o Age: 18-65 years.

    • Hearing level: Patients with normal hearing or mild to moderate sensorineural hearing loss (to ensure homogeneity of the sample) (National Institute for Health and Care Excellence, 2020)
    • Complaint: patients with chronic subjective tinnitus (> 3 months).
    • Psychological state: Patients with stable general and psychological condition.

Exclusion criteria

Exclusion Criteria:

  • o Age: \<18, >65 years

    • Hearing level: Patients with severe hearing loss not suitable for sound therapy
    • Complaint: Objective tinnitus (vascular or muscular origin)
    • Psychological state: Patients with active psychiatric disorders requiring immediate intervention.
    • Active middle or external ear disease
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    Group A: patients will receive Sound Therapy

    Behavioral: Group A: sound therapy

  • Active comparator
    Group B: patients will receive Cognitive Behavioral Therapy (CBT).

    Behavioral: Group B: Cognitive Behavioral Therapy

  • Active comparator
    Group C: patients will receive Combined CBT + Sound Therapy.

    Behavioral: Group A: sound therapy · Behavioral: Group B: Cognitive Behavioral Therapy · Behavioral: Group C: Combined CBT + Sound Therapy

Interventions

  • BehavioralGroup A: sound therapy

    Group A: Sound Therapy * Patients will receive individualized sound therapy using broadband noise or tinnitus maskers. * Daily use recommended for 2-4 hours/day. * Duration: 6 weeks. * Patient will be instructed on habituation-based listening techniques

  • BehavioralGroup B: Cognitive Behavioral Therapy

    Group B: Cognitive Behavioral Therapy (CBT) • Structured CBT program consisting of 6 sessions over 6 weeks. Each session categorization: * Psychoeducation about tinnitus * Cognitive restructuring of negative thoughts * Relaxation techniques (breathing exercises, muscle relaxation) * Attention diversion strategies * Sleep hygiene education

  • BehavioralGroup C: Combined CBT + Sound Therapy

    Group C: Combined Therapy • Patients will receive both sound therapy and CBT simultaneously following the same protocol as above.

06

What researchers measure

Primary outcomes

  1. Primary outcome: Changes in tinnitus severity

    Assessment of tinnitus severity using the Tinnitus Functional Index (TFI) . Higher scores indicate greater tinnitus severity. the TFI total score ranges from 0 to 100, with higher score s indicating greater tinnitus severity and functional impact

    Time frame: Baseline, immediately after completion of treatment , and 3 months after completion of treatment

Secondary outcomes

  1. chang in Visual Analog Scale (VAS) score

    Assessment of tinnitus severity using the Visual Analog Scale (VAS) . the VAS score ranges from 0 to 10, with 0 indicate no tinnitus and 10 indicates the worst imaginable tinnitus. higher scores indicating greater tinnitus severity

    Time frame: Baseline, immediately after completion of treatment , and 3 months after completion of treatment

  2. change in Tinnitus Handicap Inventory (THI) score

    Assessment of tinnitus-related handicap and quality of life using Tinnitus Handicap Inventory (THI). the THI total score ranges from 0 to 100, with higher scores indicating greater tinnitus-related handicap and poorer quality of life.

    Time frame: Baseline, immediately after completion of treatment , and 3 months after completion of treatment

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided — No decision has been made regarding the sharing of individual participant data at this time

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jun 2026; primary completion for Sep 2026, 3 months later.

Of 133 non-industry interventional studies with no phase under Tinnitus, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 38. This study's planned 3 months is below that.

Counting every sponsor, half of 151 studies reached it within 17 months; a quarter within 10 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 11, 2026
First posted
Jun 24, 2026
StartEst.
Jun 10, 2026
Primary completionEst.
Sep 10, 2026
CompletionEst.
Dec 10, 2026
Last update
Jun 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07665385
Lead sponsor
Sohag University
Responsible party
Aya Ahmed Elsayed (Resident at Audio-Vestibular unit ENT department at Sohag university hospital, Sohag University) — Principal investigator
First posted
Jun 24, 2026
Start date
Jun 10, 2026 (estimated)
Primary completion
Sep 10, 2026 (estimated)
Completion
Dec 10, 2026 (estimated)
Last update
Jun 30, 2026

Study contacts

Aya Ahmed Elsayed Abdelaal, Resident doctor
Contact
princess.aya1297@gmail.com
01147206609

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion